Bunge Stock Could $134 by Year End, JPMorgan Analyst Says
JPMorgan's revised target to $134 underscores a brighter backdrop for Bunge as the Viterra deal closes and 2026 biofu...
Compare safety profiles of hot versus cold wallets and learn best practices to keep your funds secure in daily use.
20,484 articlesJPMorgan's revised target to $134 underscores a brighter backdrop for Bunge as the Viterra deal closes and 2026 biofu...
Vitalik Buterin unveiled a three- to four-year Lean Ethereum upgrade, placing ETH’s institutional appeal on a four-ye...
As market conditions shift in 2026, debates over when to claim Social Security intensify. Suze Orman right about dela...
Bitcoin traders faced a fresh test as a leading corporate BTC holder dumped 3,588 coins for $216 million. The move co...
As Schwab prepares to report Q4 2025 results, investors want clarity on what drives earnings and where risks lie. Thi...
Investors wonder about the path ahead for Lucid stock. This guide lays out three scenarios, the key drivers, and conc...
Alibaba's profits falling here's headlines grab attention, but the real story is a company in transition. This guide ...
Analysts warn that the stock market’s double bubble could burst if corporate earnings fail to keep pace with lofty pr...
In 2026, breadth returns as equal-weight ETFs beat the S&P 500, nudging investors toward diversified exposure. Here a...
Nike's quarterly results offer more than sneaker news. This guide breaks down the numbers, the stock reaction, and ac...
A sweeping defense modernization plan totaling $185 billion could lift software-focused players like Palantir as miss...
ADA pulled back after a sharp weekly surge, with derivatives data signaling waning momentum and potential shifts in t...